LFG
ANGO icon

Larson Financial Group’s AngioDynamics ANGO Stock Holding History

Larson Financial Group’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$260 Buy
20
+4
+25% +$46 ﹤0.01% 3577
2026
Q1 		$182 Hold
16
– – ﹤0.01% 3464
2025
Q4 		$205 Hold
16
– – ﹤0.01% 3267
2025
Q3 		$179 Hold
16
– – ﹤0.01% 3272
2025
Q2 		$159 Hold
16
– – ﹤0.01% 3101
2025
Q1 		$150 Hold
16
– – ﹤0.01% 2846
2024
Q4 		$147 Buy
+16
New +$118 ﹤0.01% 2522

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.7M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WCM
Weber Capital Management San Francisco, California $118M AUM
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Larson Financial Group's ANGO Position: Q2 2026 in Review

Larson Financial Group increased its AngioDynamics (ANGO) stake by 25% in Q2 2026, buying an estimated $46 and bringing the position to 20 shares worth $260. The position accounts for ﹤0.01% of the portfolio, ranked #3577.

Larson Financial Group first reported a position in ANGO in Q4 2024 and has held it in 7 quarters since. 161 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • Larson Financial Group held 20 shares of AngioDynamics worth $260 as of Q2 2026.
  • Larson Financial Group bought 4 AngioDynamics shares in Q2 2026, an estimated $46.
  • AngioDynamics made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #3577 holding.
  • Larson Financial Group first reported a position in AngioDynamics in Q4 2024 and has held it in 7 quarters since.
  • 161 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.